In vitro and in vivo performance of cryopreserved MSC-coated beta-TCP scaffolds for bone regeneration

While autologous bone grafting remains the gold standard for treating delayed and non-healing bone defects, its associated complications highlight the need for alternative approaches. Bone tissue engineering (BTE) offers a promising solution by combining bone-forming stem cells with scaffolds. However, [for full text, please go to the a.m. URL]